The expanding back of the eye disorders market reflects continued investment in therapies for conditions such as diabetic macular edema, age-related macular degeneration, diabetic retinopathy and retinal vein occlusion.
The market was valued at approximately USD 17.06 billion in 2025 and is projected to reach USD 18.28 billion in 2026 and USD 41.56 billion by 2035, representing a CAGR of 9.6%.
For more information on the Back of the Eye Disorders Market, visit:
https://www.rootsanalysis.com/....reports/back-of-the-
Aimer
Commentaire
Partagez
